Inorganic phosphate and anionic lipid headgroups in membranes and solution

Inorganic phosphate and anionic lipid headgroups in membranes and solution represent a composite pharmacological target essential for the activity of lipoglycopeptide antibiotics such as dalbavancin and oritavancin. These components are primarily located on the surface of the bacterial cytoplasmic membrane in Gram-positive bacteria. The anionic nature of the lipid headgroups, such as phosphatidylglycerol and cardiolipin, along with the presence of inorganic phosphate, provides a docking environment for the hydrophobic side chains of these antibiotics (DrugBank, 2024). This membrane anchoring significantly enhances the drug's affinity for its primary substrate, the D-alanyl-D-alanine terminus of cell wall precursors, thereby inhibiting peptidoglycan cross-linking. Additionally, the interaction with the membrane can lead to direct disruption of membrane integrity, resulting in depolarization and rapid bacterial cell death (Nannini et al., 2010). This dual mechanism makes the target critical for treating serious infections caused by multidrug-resistant organisms like Methicillin-resistant Staphylococcus aureus (MRSA).

Other names

Bacterial membrane lipidsAnionic phospholipidsMembrane phosphate groupsBacterial cytoplasmic membrane components

Lipoglycopeptide antibiotics utilize a lipophilic side chain to anchor into the anionic lipid headgroups and inorganic phosphate of the bacterial membrane. This anchoring stabilizes the drug's interaction with the D-Ala-D-Ala terminus of peptidoglycan precursors, inhibiting cell wall synthesis and causing membrane depolarization (DrugBank, 2024; Belley et al., 2010).